Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2006The Journal of Clinical Endocrinology & Metabolism

Influence of the BRAF V600E Mutation on Expression of Vascular Endothelial Growth Factor in Papillary Thyroid Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

YJYoung Suk JoYonsei UniversitySLShengjin LiDalian Medical UniversityJSJung Hun SongChungnam National University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jo et al. (2006) studied this question.

synapsesocial.com/papers/69f371fcdaf2c6f3100dbd49https://doi.org/10.1210/jc.2005-2836
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevalences of G<sub>s</sub>α, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population1998 · 61 citations
  2. 2The Expression of Vascular Endothelial Growth Factor and the Type 1 Vascular Endothelial Growth Factor Receptor Correlate with the Size of Papillary Thyroid Carcinoma in Children and Young Adults2000 · 110 citations
  3. 3Detection of RET/PTC Oncogene Rearrangements in Korean Papillary Thyroid Carcinomas1999 · 34 citations
  4. 4Activation of Signal Transducer and Activator of Transcription 3 by Oncogenic RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Tyrosine Kinase: Roles in Specific Gene Regulation and Cellular Transformation2003 · 64 citations
  5. 5Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma1995 · 56 citations